Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 26, 2022; 10(33): 12146-12155
Published online Nov 26, 2022. doi: 10.12998/wjcc.v10.i33.12146
Table 1 Comparison of general data of the two groups of patients (mean ± SD)
Index
Group A (n = 60)
Group B (n = 60)
t/χ2 value
P value
Age (yr)69.6 ± 5.370.3 ± 5.7-0.6970.487
Height (cm)165.0 ± 6.1163.9 ± 5.51.0370.302
Body weight (kg)125.1 ± 9.7126.4 ± 7.5-0.8210.413
SBP (mmHg)129.5 ± 7.6128.0 ± 8.21.0390.301
DBP (mmHg)75.2 ± 6.976.8 ± 7.7-1.1990.233
HR (beats/min)76.4 ± 8.175.0 ± 7.01.0130.313
Sex, n (%)0.8620.353
Male33 (55.00)38 (63.33)
Female27 (45.00)22 (36.67)
hypertension, n (%)1.2690.260
Yes26 (43.33)20 (33.33)
No34 (56.67)40 (66.67)
Diabetes, n (%)1.7130.191
Yes11 (18.33)6 (10.00)
No49 (81.67)54 (90.00)
ASA stage, n (%)2.8740.238
I stage15 (25.00)10 (16.67)
II stage35 (58.33)33 (55.00)
III stage10 (16.67)17 (28.33)
Table 2 Comparison of surgical indicators between the two groups (mean ± SD)
Group
Operation time (min)
Anesthesia time (min)
Total rehydration (mL)
Urine volume (mL)
Group A (n = 60)216.3 ± 20.5233.8 ± 19.52568.1 ± 208.4398.5 ± 58.1
Group B (n = 60)212.0 ± 22.7229.5 ± 22.82590.4 ± 211.7410.3 ± 63.5
t value1.0891.110-0.581-1.062
P value0.2780.2690.5620.290
Table 3 Comparison of surgical indicators between the two groups (mean ± SD)
Group
Operation time (min)
Anesthesia time (min)
Total rehydration (mL)
Urine volume (mL)
Group A (n = 60)216.3 ± 20.5233.8 ± 19.52568.1 ± 208.4398.5 ± 58.1
Group B (n = 60)212.0 ± 22.7229.5 ± 22.82590.4 ± 211.7410.3 ± 63.5
t value1.0891.110-0.581-1.062
P value0.2780.2690.5620.290
Table 4 Comparison of airway compliance indexes between the two groups (mean ± SD)
Group
T0
T1
T2
T3
Ppeak (cmH2O)
Group A (n = 60)15.36 ± 2.4420.06 ± 1.9821.58 ± 2.7417.41 ± 2.80
Group B (n = 60)16.11 ± 2.7018.62 ± 2.7020.67 ± 2.6818.15 ± 2.76
t value-1.5963.3311.839-1.458
P value0.1130.0010.0680.148
Pmean (cmH2O)
Group A (n = 60)8.51 ± 1.8410.33 ± 1.9611.36 ± 2.2410.71 ± 2.54
Group B (n = 60)8.93 ± 2.009.81 ± 2.7110.95 ± 2.4610.40 ± 2.75
t value-1.1971.2040.9550.641
P value0.2340.2310.3420.522
Cdyn (cmH2O)
Group A (n = 60)38.64 ± 3.1130.52 ± 3.0429.64 ± 3.1133.75 ± 3.58
Group B (n = 60)39.33 ± 4.0528.64 ± 3.5828.11 ± 2.9032.68 ± 2.83
t value-1.0473.1012.7871.816
P value0.2970.0020.0060.072
Table 5 Comparison of serum inflammatory factor levels before and after operation between the two groups (mean ± SD)
Group
TNF-α (ng/mL)
IL-6 (pg/mL)
IL-10 (pg/mL)
Preoperative
4 h after operation
Preoperative
4 h after operation
Preoperative
4 h after operation
Group A (n = 60)43.26 ± 6.8076.65 ± 8.7747.14 ± 5.5056.94 ± 7.3034.62 ± 5.1029.51 ± 4.75
Group B (n = 60)45.10 ± 6.5589.28 ± 12.6445.03 ± 6.2869.71 ± 10.3836.36 ± 6.1525.83 ± 5.08
t value-1.510-6.3591.958-7.795-1.6874.099
P value0.1340.0000.0530.0000.0940.000
Table 6 Comparison of hemodynamic indexes between two groups of patients before and after operation (mean ± SD)
Group
T0
T1
T2
T3
CO (L/min)
Group A (n = 60)4.81 ± 0.854.43 ± 0.804.36 ± 0.754.51 ± 0.83
Group B (n = 60)4.95 ± 0.904.30 ± 0.784.13 ± 0.804.37 ± 0.86
t value-0.8760.9011.6250.907
P value0.3830.3690.1070.366
CI [L/(min·m2)]
Group A (n = 60)4.11 ± 0.403.83 ± 0.463.51 ± 0.423.68 ± 0.40
Group B (n = 60)4.26 ± 0.443.90 ± 0.503.30 ± 0.393.53 ± 0.44
t value-1.954-0.7982.8381.954
P value0.0530.4260.0050.053
SVI (mL/m2)
Group A (n = 60)47.52 ± 4.6344.03 ± 3.7543.85 ± 3.1145.08 ± 4.09
Group B (n = 60)48.36 ± 4.9043.41 ± 4.0341.66 ± 3.5744.13 ± 4.37
t value-0.9650.8723.5831.229
P value0.3360.3850.0000.221
MAP (mmHg)
Group A (n = 60)97.63 ± 4.1588.16 ± 5.2087.11 ± 4.64102.84 ± 5.00
Group B (n = 60)98.90 ± 4.6886.85 ± 4.9686.08 ± 5.03104.07 ± 4.86
t value-1.5731.4121.166-1.366
P value0.1180.1610.2460.174
Table 7 Comparison of the complication rate between the two groups
Group
Lung infection
Atelectasis
Other
Complication rate (%)
Group A (n = 60)2013 (5.00)
Group B (n = 60)3137 (11.67)
χ2 value1.745
P value0.186